Corrigendum to "European guidelines for the diagnosis, treatment and follow-up of breast lesions with uncertain malignant potential (B3 lesions) developed jointly by EUSOMA, EUSOBI, ESP (BWG) and ESSO" [Eur J Surg Oncol 50 (1) (January 2024) 107292]

Isabel T Rubio¹, Lynda Wyld², Lorenza Marotti³, Alexandra Athanasiou⁴, Peter Regitnig⁵, Giuseppe Catanuto⁶, Jan W Schoones⁷, Marzia Zambon⁸, Julia Camps⁹, Donatella Santini¹⁰, Jill Dietz¹¹, Francesco Sardanelli¹², Zsuzsanna Varga¹³, Marjolein Smidt¹⁴, Nisha Sharma¹⁵, Abeer M Shaaban¹⁶, Fiona Gilbert¹⁷

Affiliations

¹ Breast Surgical Oncology, Clinica Universidad de Navarra, Madrid, Spain; European Society of Breast Cancer Specialists (EUSOMA), Florence, Italy; European Society of Surgical Oncology (ESSO), Brussels, Belgium. Electronic address: irubior@unav.es.
² Department of Oncology and Metabolism, University of Sheffield Medical School, Beech Hill Road, Sheffield, S10 2RX, UK; Doncaster and Bassetlaw Teaching Hospitals NHS Foundation Trust, Doncaster, UK.
³ European Society of Breast Cancer Specialists (EUSOMA), Florence, Italy.
⁴ Breast Imaging Department, MITERA Hospital, Athens, UK.
⁵ Diagnostic and Research Institute of Pathology, Medical University of Graz, Graz, Austria.
⁶ Humanitas-Istituto Clinico Catanese Misterbianco, Italy; Fondazione G.Re.T.A., ETS, Napoli, Italy.
⁷ Research Policy & Graduate School Advisor, Leiden University Medical Center Leiden, the Netherlands.
⁸ Europa Donna - The European Breast Cancer Coalition, Milan, Italy.
⁹ Breast Health Units in Ribera Salud Hospitals.Valencia, Spain.
¹⁰ Department of Pathology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Italy.
¹¹ The American Society of Breast Surgeons, Columbia, MD, USA.
¹² Department of Biomedical Sciences for Health, Università Degli Studi di Milano, Milan, Italy; Unit of Radiology, IRCCS Policlinico San Donato, San Donato Milanese, Milan, Italy.
¹³ Department of Pathology and Molecular Pathology, University Hospital Zurich, Zurich, Switzerland.
¹⁴ GROW-School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, the Netherlands; Department of Surgery, Maastricht University Medical Centre, Maastricht, the Netherlands.
¹⁵ Breast Unit, Level 1 Chancellor Wing, St James Hospital, Beckett Street Leeds, West Yorkshire, LS9 7TF, UK.
¹⁶ Cellular Pathology, Queen Elizabeth Hospital Birmingham, Birmingham, UK; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK.
¹⁷ Department of Radiology, University of Cambridge, Cambridge Biomedical Campus, UK.

PMID: 38246851
DOI: 10.1016/j.ejso.2023.107943

Published Erratum

Corrigendum to "European guidelines for the diagnosis, treatment and follow-up of breast lesions with uncertain malignant potential (B3 lesions) developed jointly by EUSOMA, EUSOBI, ESP (BWG) and ESSO" [Eur J Surg Oncol 50 (1) (January 2024) 107292]

Isabel T Rubio et al. Eur J Surg Oncol. 2024 Mar.

. 2024 Mar;50(3):107943.

doi: 10.1016/j.ejso.2023.107943. Epub 2024 Jan 20.

Authors

Affiliations

¹ Breast Surgical Oncology, Clinica Universidad de Navarra, Madrid, Spain; European Society of Breast Cancer Specialists (EUSOMA), Florence, Italy; European Society of Surgical Oncology (ESSO), Brussels, Belgium. Electronic address: irubior@unav.es.
² Department of Oncology and Metabolism, University of Sheffield Medical School, Beech Hill Road, Sheffield, S10 2RX, UK; Doncaster and Bassetlaw Teaching Hospitals NHS Foundation Trust, Doncaster, UK.
³ European Society of Breast Cancer Specialists (EUSOMA), Florence, Italy.
⁴ Breast Imaging Department, MITERA Hospital, Athens, UK.
⁵ Diagnostic and Research Institute of Pathology, Medical University of Graz, Graz, Austria.
⁶ Humanitas-Istituto Clinico Catanese Misterbianco, Italy; Fondazione G.Re.T.A., ETS, Napoli, Italy.
⁷ Research Policy & Graduate School Advisor, Leiden University Medical Center Leiden, the Netherlands.
⁸ Europa Donna - The European Breast Cancer Coalition, Milan, Italy.
⁹ Breast Health Units in Ribera Salud Hospitals.Valencia, Spain.
¹⁰ Department of Pathology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Italy.
¹¹ The American Society of Breast Surgeons, Columbia, MD, USA.
¹² Department of Biomedical Sciences for Health, Università Degli Studi di Milano, Milan, Italy; Unit of Radiology, IRCCS Policlinico San Donato, San Donato Milanese, Milan, Italy.
¹³ Department of Pathology and Molecular Pathology, University Hospital Zurich, Zurich, Switzerland.
¹⁴ GROW-School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, the Netherlands; Department of Surgery, Maastricht University Medical Centre, Maastricht, the Netherlands.
¹⁵ Breast Unit, Level 1 Chancellor Wing, St James Hospital, Beckett Street Leeds, West Yorkshire, LS9 7TF, UK.
¹⁶ Cellular Pathology, Queen Elizabeth Hospital Birmingham, Birmingham, UK; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK.
¹⁷ Department of Radiology, University of Cambridge, Cambridge Biomedical Campus, UK.

PMID: 38246851
DOI: 10.1016/j.ejso.2023.107943

No abstract available

PubMed Disclaimer

Erratum for

European guidelines for the diagnosis, treatment and follow-up of breast lesions with uncertain malignant potential (B3 lesions) developed jointly by EUSOMA, EUSOBI, ESP (BWG) and ESSO.
Rubio IT, Wyld L, Marotti L, Athanasiou A, Regitnig P, Catanuto G, Schoones JW, Zambon M, Camps J, Santini D, Dietz J, Sardanelli F, Varga Z, Smidt M, Sharma N, Shaaban AM, Gilbert F. Rubio IT, et al. Eur J Surg Oncol. 2024 Jan;50(1):107292. doi: 10.1016/j.ejso.2023.107292. Epub 2023 Nov 27. Eur J Surg Oncol. 2024. PMID: 38061151

Publication types

Actions

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Corrigendum to "European guidelines for the diagnosis, treatment and follow-up of breast lesions with uncertain malignant potential (B3 lesions) developed jointly by EUSOMA, EUSOBI, ESP (BWG) and ESSO" [Eur J Surg Oncol 50 (1) (January 2024) 107292]

Affiliations

Corrigendum to "European guidelines for the diagnosis, treatment and follow-up of breast lesions with uncertain malignant potential (B3 lesions) developed jointly by EUSOMA, EUSOBI, ESP (BWG) and ESSO" [Eur J Surg Oncol 50 (1) (January 2024) 107292]

Authors

Affiliations

Erratum for

Publication types